Intravascular Ultrasound (IVUS) in Complex Aortic Endovascular Interventions

Sponsor
University Hospital Muenster (Other)
Overall Status
Recruiting
CT.gov ID
NCT04663074
Collaborator
(none)
100
6
48
16.7
0.3

Study Details

Study Description

Brief Summary

The study aims to investigate the applicability of intravascular ultrasound (IVUS) in the endovascular therapy of juxta-, supra- and thoracoabdominal aortic aneurysms.

The focus of the study is on the intraoperative and postoperative evaluation of the geometric data of bridging stentgrafts in terms of patency, occurrence of stenosis and/or kinking.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: IVUS control

Detailed Description

Intravascular ultrasound (IVUS) is an already validated diagnostic method increasingly use in endovascular interventions. In contrast to conventional digital subtraction angiography (DSA), the IVUS provides in vivo real-time vessel images. Furthermore, its accuracy has been examined in histological studies, which could report of a good correlation regarding the vessel diameters (Jin ZG et al. Int J Cardiovasc Imaging. 2017 Feb; 33 (2): 153-160.).

Stenosis and/or kinkings of stents or stentgrafts as well as their fully expansion and morphology can be assessed with the use of IVUS.

The IVUS has already been used successfully in the context of endovascular treatment of infrarenal aortic aneurysms (Endovascular Aortic Repair or EVAR). Here, the IVUS has proven to be a valuable diagnostic instrument to examine the anatomy of the inserted stent grafts intraoperatively and to detect any abnormalities. In addition, the use of IVUS led to a significant reduction in the use of iodine-containing contrast media and radiation exposure as part of these complex endovascular interventions (Pecoraro F et al. Ann Vasc Surg. 2019 Apr; 56: 209-215.).

In the endovascular therapy of thoracoabdominal as well as suprarenal and juxtarenal aortic aneurysms, stent grafts with recesses (windows - Fenestrated EVAR or FEVAR) or side arms (branches - Branched EVAR or BEVAR) for the renovisceral vessels (truncus coeliacus, superior mesenteric artery and renal arteries) are implanted. In exceptional cases, the renovisceral vessels are supplied with stent grafts that are implanted in parallel to the aortic stent grafts (Chimney-Technique). These branches or windows are then connected to the corresponding target vessels via a bridging stent graft. The patency and anatomy of the bridging stent grafts are usually checked intraoperatively by angiography. The dynamics of the contrast agent flow and the X-ray images of the framework of the stent graft help in assessing their patency as well as the absence of structural problems.

The Computed Tomographic Angiography (CTA) is considered the gold standard as diagnostic method to assess the patency and anatomy of the stentgrafts postoperatively. This diagnostic method bares with it the exposure to relevant radiation dose as well as to contrast media. However, CTA scans do not provide in vivo real-time vessel images.

Furthermore, in case of pathological findings a new intervention may be necessary. The IVUS technique overcomes these issues due to its low invasiveness and its possible use during the index procedure. This can lead to the immediate identification of eventual structural problems of the bridging stent grafts which can jeopardize their patency and to correct them already during the index procedure.

The use of the IVUS during FEVAR, BEVAR and CHEVAR has already been implemented in our clinical routine. At our knowledge, a prospective collection of anatomical-geometric data by IVUS in complex endovascular treatments of complex aortic aneurysm has not been yet reported.

The aim of the current study is the retrospective evaluation of the anatomical-geometric data already collected by IVUS as well as the prospective collection of new data regarding the patency and anatomy of bridging stent grafts.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Register of Anatomical / Geometric Data Obtained by Intravascular Ultrasound (IVUS) Examinatio´n of Bridging Stent Grafts in Complex Aortic Interventions
Actual Study Start Date :
May 22, 2020
Anticipated Primary Completion Date :
May 22, 2022
Anticipated Study Completion Date :
May 22, 2024

Arms and Interventions

Arm Intervention/Treatment
IVUS Group

Patients treated by BEVAR/CHEVAR/FEVAR due to a thoracoabdominal aneurysm.

Diagnostic Test: IVUS control
Intravascular Control of the bridging stentgrafts during branched EVAR
Other Names:
  • Volcano Philips
  • Outcome Measures

    Primary Outcome Measures

    1. bSG patency [5 years]

      Patency of the bridging stentgraft

    Secondary Outcome Measures

    1. Geometrical changes [5 years]

      Geometrical changes of the bridging stentgrafts during follow-up

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age over 18 years

    • Elective or emergency treatment of an aortic aneurysm with a branched or fenestrated stent graft or with the aid of parallel stent grafts´(chimney)

    • Patient capable of giving informed consent

    Exclusion Criteria:
    • Patients who are already participating in another study

    • child bearing or breast feeding females

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Vascular Surgery, Rigshopitalet Copenhagen Denmark
    2 Klinik für Gefäßchirurgie, St. Franziskus-Hospital Münster Germany
    3 Muenster University Hospital Münster Germany
    4 Vascualar Surgery, Nocsae Nuovo Ospedale Civile di Baggiovara St. Agostiono Estense Modena Italy
    5 Vascular and Endovascular Surgery Division, Padua University Padua Italy
    6 Division of Vascular Surgery, Uppsala University Upplands Väsby Sweden

    Sponsors and Collaborators

    • University Hospital Muenster

    Investigators

    • Principal Investigator: Alexander Oberhuber, University Hospital Muenster

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University Hospital Muenster
    ClinicalTrials.gov Identifier:
    NCT04663074
    Other Study ID Numbers:
    • 01_2020
    First Posted:
    Dec 10, 2020
    Last Update Posted:
    May 25, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital Muenster
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 25, 2022